Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis

Background Both early correction of anemia and preserving residual renal function (RRF) are reported to improve patient survival. The aim of this study was to explore the efficacy and safety of Roxadustat for treatment of renal anemia in patients new to peritoneal dialysis (PD) and to assess its imp...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tong Wu, Yuanyuan Qi, Shuang Ma, Lijie Zhang, Xinyu Pu, Kui Chen, Ying Zhao, Shenghua Sang, Jing Xiao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2022-12-01
Colecção:	Renal Failure
Assuntos:	Roxadustat peritoneal dialysis renal anemia residual renal function
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/0886022X.2022.2050754
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!